PANVAX® PANDEMIC INFLUENZA VACCINE (ADJUVANTED) 10ML SUSPENSION FOR INJECTION VIAL

Product Information

Registration Status: Active

PANVAX® PANDEMIC INFLUENZA VACCINE (ADJUVANTED) 10ML SUSPENSION FOR INJECTION VIAL is approved to be sold in Singapore with effective from 2019-09-06. It is marketed by SEQIRUS PTE LTD, with the registration number of SIN15801P.

This product contains Pandemic Influenza Virus Type A, Inactivated And Disrupted 30 mcg HA / 0.5 ml in the form of INJECTION, SUSPENSION. It is approved for INTRAMUSCULAR use.

This product is manufactured by Seqirus Pty Ltd in AUSTRALIA.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Pandemic Influenza Virus Type A, Inactivated And Disrupted

Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank